Julia Wang, CFO of Labcorp, to Address UBS Global Healthcare Conference on November 10

Labcorp's Upcoming Participation at the UBS Global Healthcare Conference

Labcorp, recognized as a leading entity in laboratory services worldwide, has announced that their Chief Financial Officer, Julia Wang, will be taking center stage at the prestigious UBS Global Healthcare Conference on November 10, 2026, at 8:45 AM ET. This occasion is a significant platform for Labcorp to showcase its innovations and commitment to healthcare advancements.

As healthcare continues to evolve, Labcorp remains at the forefront, assisting doctors, hospitals, researchers, and pharmaceutical companies in making informed decisions through its comprehensive laboratory capabilities. Julia Wang's involvement in this event underscores the company's dedication to transparency and collaboration within the healthcare community.

The conference will feature a live audio webcast, which interested parties can access through Labcorp's Investor Relations website. Additionally, the chat will be archived for 180 days, allowing access to insights shared during the session long after the event concludes. This feature ensures that the information presented reaches a wider audience, providing an opportunity for learning and discussion in the broader context of healthcare and laboratory services.

Labcorp, operating under the ticker symbol NYSE: LH, boasts a remarkable workforce of nearly 71,000 employees. It serves clients in around 100 countries around the globe. The company has played a crucial role in supporting the development of over 85% of new drugs and therapeutic products approved by the FDA in 2025, signifying its pivotal position in the healthcare sector. Moreover, Labcorp has conducted over 750 million tests for patients worldwide, impacting countless lives through its services.

One of the core missions of Labcorp is to provide essential insights that help improve health outcomes and overall quality of life. The company achieves this through unparalleled diagnostics and drug development capabilities that ensure precise and reliable results for healthcare providers and patients alike.

As the healthcare landscape continues to change rapidly, conferences like the UBS Global Healthcare Conference provide a valuable opportunity for industry leaders to share their insights and collaborative efforts towards common goals. Julia Wang's participation is a testament to Labcorp's commitment to engage with other thought leaders in the field and highlight the importance of innovation in healthcare delivery.

For those interested in learning more about Labcorp's contributions to healthcare and its innovative approaches, further details can always be found on their official website at www.labcorp.com. There, stakeholders can explore the extensive range of services that the company offers and its significant role in advancing medical science. This event promises to be not just informative but also a step forward in discussions about the future of healthcare services.

As the date approaches, healthcare professionals, investors, and anyone interested in the progression of the medical industry should mark their calendars for this significant event. Julia Wang's insights are sure to provide valuable perspectives on the innovations and strategies Labcorp brings to the table as a global leader in laboratory services.